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Literature review 
 
About cancers 
 
According to data from 2004 from the WHO, cancer is the third leading cause of death after 
cardiovascular and infectious diseases. In 2008, approximately 12.7 million new cancer cases 
were registered and 7.6 million persons died from cancer all over the world. Cancer has 
unfortunately been demonstrated to be the second leading cause of death also in our country 
(23%). In Hungary in 2008, 70,527 new cancer cases were registered (36,190 males and 
34,337 females), and the number of deaths from cancer reached nearly 33,000.  With this 
mortality rate, our country occupies the first place in mortality statistics of the member states 
in the European Union.   
About breast cancer in short 
 
Breast cancer is the most common type of cancer among females in our country. Its 
oncological therapy is a complex medical process. The most fundamental treatment is 
surgery, which attempts to remove the tumor and its surrounding tissues containing cancerous 
cells. Moreover, numerous other types of treatment can be applied: chemotherapy, radiation 
therapy, hormone therapy, and in certain cases immunotherapy.  
About prostate cancer in short  
 
Prostate cancer is the fourth most common type of cancer among males in our country. 
During its oncotherapy the following types of treatment can be applied: observation, surgery, 
hormone therapy, and radiation therapy.  
The radiation therapy 
 
One of the most important oncotherapies is radiation therapy, which means the use of ionizing 
radiation of high energy. Gray (Gy) is the derived unit of ionizing radiation dose. Two thirds 
of cancer patients receive radiation therapy during their treatment process.  This type of 
treatment can be curative or palliative. In the case of curative radiotherapy, irradiation can 
bring complete recovery by itself, together with chemotherapy, or after operation.  It aims to 
destroy all the cancerous cells. The aim of palliative radiotherapy is to manage pain and other 
symptoms and to enhance the quality of life in advanced cancers.  Two forms of radiation 
therapy exist: external and internal radiotherapy. In the case of external radiotherapy, 
irradiation reaches the organ through the skin and impinges to the tumor and its surrounding 
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areas with penetration of the tissue.  Internal radiotherapy uses radioactive metals or liquids 
(isotopes) to treat tumors.  
The efficacy of radiotherapy is based upon the mechanism that (as medical experience has 
pointed out) the rapidly dividing cancer cells are more sensitive to radiation than healthy 
cells. However, as a consequence of this treatment the surrounding healthy cells may also be 
injured, which causes early and late side-effects. Among the side-effects of radiotherapy there 
are common ones experienced by most patients (e.g., fatigue, changes in the skin), and there 
may be specific side-effects depending on the place of irradiation (e.g., coughing in the case of 
chest irradiation).  
About oncopsychology  
The health care system puts greater stress on cancer patients‟ somatic healing or the 
management of somatic symptoms, but psychological care is also an important part of the 
treatment. For this “mission” a borderline discipline of oncology and psychology is 
responsible, termed oncopsychology (in the USA it is named psycho-oncology). According to 
Holland and Weiss‟s definition, oncopsychology deals with the following two psychological 
dimensions of cancer:  
(1) the psychological reactions of cancer patients and their families at all stages of the 
disease and the stress on oncological staff, 
(2) the psychological, social, and behavioral factors that contribute to cancer causes and 
survival. 
Quality of life 
 
During the treatment of chronic disease, several medical interventions can be completed that 
can prolong the duration of patients‟ lives. Certain treatments may change the parameters of 
the disease only to a small degree, but the quality of life of the patient improves. Other 
treatments (e.g., chemotherapy) may increase the patient‟s chance for survival, but because of 
their aggressive side-effects they may impair the patient‟s general condition. It can be a 
relevant question as to which treatments and interventions are “worthwhile” for patients. The 
measurement of health-related quality of life (HRQoL) can help to answer this question.  
HRQoL is usually regarded as a multidimensional construct that includes several core 
domains, such as (1) mental functioning; (2) physical functioning; (3) role functioning; and 
(4) social functioning. The essence of this concept is: to what extent is a person contented 
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with his/her actual functioning (physical, psychological, and social), and how does he/she 
measure them in comparison with what he/she holds as ideal.  
Recently, oncology and other divisions of medicine have placed great emphasis on measuring 
patients‟ HRQoL, which is an important indicator of treatment outcomes and provides 
information about the side effects of treatment. Moreover, HRQoL is a relevant determinant 
of cancer patients‟ judgments and their adherence to oncological treatments. 
The impact of external radiation therapy on health-related quality of life 
 
Radiotherapy (RT) is an increasingly used oncological treatment, with growing attention paid 
to its effects on HRQoL. Studies with RT recipients have measured HRQoL using the 
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC QOL-C30), the Functional Assessment of Cancer Therapy Scale (FACT), and the 
Short Form-36 (SF-36) questionnaire. These studies can be divided into the following two 
groups: half assess changes in HRQoL before, during, and after RT using a longitudinal 
design, whereas the other half compare the HRQoL of RT recipients to non-recipients or RT 
recipients to healthy comparison subjects.   
The number of longitudinal studies examining the quality of life of cancer patients during and 
after RT is, surprisingly, quite low. Several studies have shown that HRQoL significantly 
declines during RT, and then significantly improves some weeks after the treatment has 
ended. Deshields et al. found that breast cancer patients reported low levels of HRQoL at the 
conclusion of RT, but by two weeks post-treatment, their quality of life improved 
significantly and remained relatively stable at six months post-treatment. This finding 
suggests that psychological recovery occurs within a short time post-treatment. Stone et al. 
investigated HRQoL in a group of breast and prostate cancer patients receiving RT. They 
reported that there was a significant deterioration of global quality of life and some of its 
subscales (e.g., role functioning, cognitive functioning, and social functioning) between two 
points of measurement, which were pre-treatment (immediately prior to treatment) and within 
one week of the completion of RT. Another study found the same results with early-stage 
breast cancer patients. Wengström et al. revealed a small decline in HRQoL during RT, but 
post-treatment scores seemed to equalize at follow-up measures (two weeks and three months 
after RT). A study by Dow and Lafferty demonstrated that overall quality of life and its 
subdomains (e.g., social, family, and psychological/spiritual functioning) declined from the 
start of RT to the midpoint of treatment, and then improved by six months after treatment 
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ended (except for social functioning, which remained at a level that was lower than reported 
at the start of RT). By contrast, a number of studies have found that patients‟ quality of life 
remains unchanged during radiation treatment.  
Fatigue as a common side effect of radiation therapy 
 
HRQoL declines during RT partly because RT may make existing symptoms worsen or may 
produce new physical symptoms (side effects). Fatigue is a common, highly disruptive 
complaint of patients undergoing external RT, and its prevalence rates among patients 
receiving RT can reach 70% or more. A number of studies have demonstrated that fatigue 
increases during the course of RT, and then returns to pre-treatment levels several months 
after the completion of RT. In a study by Wengström et al., fatigue worsened as the course of 
RT progressed, with a prevalence rate of over 85% among breast cancer patients in the third 
and fifth weeks of treatment (87% and 90%, respectively). The pre-treatment prevalence rate 
(63%) returned by three months post-treatment. Fatigue has a relevant effect on patients‟ 
well-being, as it has been found to be the strongest determinant of overall quality of life. Lee 
et al. revealed similar results by showing that fatigue is highly predictive of lower quality of 
life upon completion of RT and also at seven months after treatment ended. Moreover, fatigue 
is the most frequently mentioned symptom during RT. 
Diagnosis of cancer as a psychological trauma 
 
The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision 
(DSM-IV-TR) provides a long list of potential psychological traumas and includes ‟being 
diagnosed with a life-threatening illness‟ as a potential cause of posttraumatic stress disorder. 
Cancer, as a life-threatening illness, could also be considered a traumatic event and may 
therefore have a number of negative consequences. The physical symptoms, which may 
include the painful side effects of treatments, may cause a number of disruptions in patients‟ 
social and family life and in their daily activities. By contrast, a growing body of literature has 
recently shown that a highly stressful life event can contribute to the experience of positive 
psychosocial changes in various life domains of patients.  
Personality development deriving from cancer: the posttraumatic growth  
 
 An oncological illness may serve as a catalyst for unexpected positive psychological changes 
in various life domains such as interpersonal relationships, self-perception, priorities, and the 
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philosophy of life. The concept of posttraumatic growth (PTG) refers to an “experience of 
positive change that occurs as a result of the struggle with highly challenging life crises”.  
Recently, a growing body of literature has demonstrated that people report positive 
consequences following a diagnosis of breast cancer, colorectal cancer, cervical cancer, 
prostate cancer, oral cavity cancer, melanoma, and Non-Hodgkin‟s lymphoma. According to 
these psycho-oncological studies, a high percentage of cancer survivors (80%) report at least 
one positive effect attributed to their cancer experience.  
Although the majority of cancer patients report PTG, it is not experienced by all cancer 
patients. It is useful to identify which potential determinants enable persons to experience 
positive changes and which do not. These determinants can be divided into two groups: 
stressor-related variables and person-related variables. In the case of cancer, stressor-related 
variables comprise the site of cancer, the stage (representing the objective severity of the 
stressor), the subjective severity of the illness, the time elapsed since diagnosis, and the types 
of oncological treatment. According to the theory of PTG, the seriousness of a traumatic event 
is a significant determinant of positive changes. The trauma should be sufficiently challenging 
to question or shatter a person‟s basic assumptions about the self and the world, which causes 
a schema change related to the experience of PTG. Studies aimed at identifying the cancer-
related correlates and predictors of PTG have revealed that PTG has been associated with the 
stage of disease, the subjective appraisal of cancer as a stressor, the receipt of chemotherapy, 
and mastectomy.  
The second group of PTG determinants are person-related variables, which encompass the 
sociodemographic characteristics and individual factors that may influence the responses to 
trauma (e.g., type of adult attachment, quality of life). Numerous studies have reported that 
women tend to report significantly more PTG than men. Moreover, younger respondents 
generally perceive more positive changes resulting from the cancer experience. Additionally, 
some studies have indicated that patients who are married or in a committed relationship 
report significantly higher levels of PTG .  
The other important person-related determinant of PTG is the type of adult attachment. 
According to the theory proposed by Salo et al., the great differences in responses to trauma 
can be explained by the type of adult attachment. Persons with different attachment styles 
learn unique ways of reacting to distress during childhood, and these models are activated 
when their safety and integrity become jeopardised. Thus, in the case of a traumatic event, 
persons with insecure attachment will either be totally overwhelmed by the threat or deny its 
significance. By contrast, securely attached persons are likely to evaluate the event in a 
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relatively realistic manner and use situation-adequate, effective coping strategies, which 
enable them to respond to trauma with more PTG than insecurely attached individuals. A 
study by Schmidt et al. supported this theory, finding that in a sample of cancer survivors, 
using positive reframing and religion as coping strategies mediated the relationship between 
PTG and secure attachment. The number of studies exploring the relationship between adult 
attachment and PTG is still quite low; only two cross-sectional studies exist. Schmidt et al. 
demonstrated that secure attachment was positively associated with the amount of growth 
experienced by cancer survivors. In addition, Salo et al. found that men with secure 
attachment reported more PTG than those without secure attachment in a sample of political 
prisoners.  
Several studies have tried to explore the potential significance of mental and physical 
adjustment in experiencing PTG. HRQoL is a widely used indicator of physical and mental 
adjustment to a physical illness. The results regarding the relationship between quality of life 
and PTG are inconsistent in the literature. In some cross-sectional studies, PTG was related to 
higher quality of life. For example, Lelorain et al. reported that the mental health and vitality 
subscales of quality of life measures were positively correlated with PTG among breast 
cancer patients. In other studies, however, no relationship was reported between PTG and 
quality of life.  
 
Cross-sectional study 
 
Research hypotheses 
 
The aim of this cross-sectional study was to explore the prevalence and nature of PTG among 
Hungarian patients with breast or prostate cancer. Moreover, it was a significant goal to 
examine the potential role of certain stressor-related and person-related variables in predicting 
the experience of PTG among cancer patients. The hypotheses of the study were as follows: 
Hypothesis 1: Hungarian cancer patients may also experience the phenomenon of PTG, 
and the majority of patients can report positive changes as a result of their oncological 
illness.  
Hypothesis 2: Regarding sociodemographic variables, patients who are younger, 
female, and married/live with a partner would be more likely to experience PTG.  
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Hypothesis 3: Among the cancer-related variables, a higher stage of disease, subjective 
severity and perceived aftermath of cancer would be significantly associated with more 
PTG.  
Hypothesis 4: The amount of time elapsed since diagnosis would not be significantly 
associated with PTG. 
Hypothesis 5: Among the oncological treatments, patients treated with chemotherapy 
and mastectomy/prostatectomy would experience more PTG compared to those who 
were not treated. Other forms of oncotherapy would not be significantly associated with 
PTG.  
Hypothesis 6: The secure type of adult attachment would be predictive of higher PTG 
compared to insecure types of adult attachment. 
Because of the highly inconsistent results of previous studies, we had no hypothesis regarding 
the relationship between PTG and HRQoL.   
Methods 
Procedure  
For this cross-sectional study, patients were recruited from the Department of Radiotherapy of 
the University of Debrecen. The inclusion criteria for the study were as follows: (1) no 
previous cancer history; (2) primary breast or prostate cancer without distant metastases; (3) 
imminent initiation of radiotherapy; and (4) above 18 years of age. The sample consisted of 
patients with either breast or prostate cancer, given that these types of cancer cause similar 
impairments to quality of life. Eligible patients were identified by a radiation oncologist and 
were then personally approached after a session of radiation simulation. Participants 
completed a written informed consent form and a questionnaire packet. All study documents 
were approved by the Medical Ethical Committee of the Medical and Health Science Center 
of the University of Debrecen.  
Participants  
The final sample used for the study consisted of 152 breast or prostate cancer patients who 
were scheduled for radiotherapy at the Department of Radiotherapy of the University of 
Debrecen (74.3% were female). The average age of the patients was 59.1 years (SD=10.77, 
range 34-80). Of the 152 participants, 65.8% were married or lived with a partner (N=100), 
and most of them (N= 95, 62.5%) had completed secondary education. The mean time since 
diagnosis was 3.5 months (SD=2.2, range 0.2-7.9), and the majority of patients sampled had 
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been diagnosed with stage I or II cancer (N=120, 78.9%). All patients had undergone some 
form of surgery, but only 17.8% (N=27) had undergone a mastectomy or prostatectomy. 
Approximately half of the participants had received chemotherapy (N=74, 48.7%), and a 
majority had undergone hormonal therapy (N=117, 77%).  
Measures 
PTG. The Posttraumatic Growth Inventory (PTGI) is a 21-item self-report questionnaire that 
measures positive changes in the aftermath of a traumatic life event. The original English 
version consists of the following five subscales: Relating to Others (e.g., “I put more effort 
into my relationships.”), New Possibilities (e.g., “I established a new path for my life.”), 
Personal Strength (e.g., “I know better that I can handle difficulties.”), Spiritual Change (e.g., 
“I have a stronger religious faith.”), and Appreciation of Life (e.g., “I can better appreciate 
each day.”). The items are rated on a 6-point Likert scale ranging from 0 (I did not experience 
this change as a result of my cancer) to 5 (I experienced this change to a great degree as a 
result of my cancer). Adding the scores of the five subscales yields a PTGI total score (range 
0-105). The Hungarian version of the PTGI, with the original 21 items and five subscales, was 
used to assess cancer-related PTG. In the present study, the internal consistency was 0.81 for 
the PTGI total score and ranged from 0.70 (Personal Strength) to 0.81 (Relating to Others) for 
the subscales.    
Adult attachment. Adult attachment style was measured using the Hungarian version of the 
36-item Experiences in Close Relationships Scale (ECRS), which asks respondents to rate 
how well each statement describes their typical feelings in relationships. Responses are 
provided on a 7-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). 
The ECRS has two subscales, Anxiety and Avoidance. The Attachment Anxiety subscale 
assesses fear of abandonment and rejection (range 18-126). The Attachment Avoidance 
subscale measures avoidance of intimacy and discomfort with closeness (range 18-126). As 
recommended by Brennan et al., persons can be placed into the following four attachment-
style categories based on their scores on the two subscales: secure, preoccupied, fearful-
avoidant, and dismissive. In the present study, the internal consistency for the ECRS total was 
0.91; the internal consistency for the subscales was 0.90 (for Attachment Avoidance) and 0.87 
(for Attachment Anxiety).  
HRQoL. Quality of life was assessed with the Hungarian version of the Functional 
Assessment of Cancer Therapy-General Questionnaire (FACT-G version 4). This 
questionnaire was originally developed and widely used for adult patients with any type of 
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tumour. It is composed of 27 questions that assess the following four subscales of HRQoL: 
Physical Well-being (PWB) (e.g., “I have pain.”- reverse item), Emotional Well-being (EWB) 
(e.g., “I feel sad.”- reverse item), Social/Family Well-being (SFWB) (e.g., “I get support from 
my friends.”), and Functional Well-being (FWB) (e.g., “I am able to work.”). Items are rated 
on a 5-point Likert scale ranging from 0 (not at all) to 4 (very much). The FACT-G total score 
(range 0-108) is the sum of the four subscale scores. Greater total scores indicate better 
HRQoL. In the current study, the Cronbach‟s alpha was 0.72 for the total score of the FACT-
G and ranged from 0.73 (for EWB) to 0.81 (for PWB) for the subscales.    
Sociodemographic and medical variables. Patients completed a questionnaire about 
sociodemographic characteristics including age, gender, marital status, and education. The 
following medical variables were derived from patients‟ medical charts: the stage of cancer, 
the type of treatment received (type of surgery, hormonal therapy, chemotherapy), and the 
length of time elapsed since diagnosis. 
Subjective severity and perceived aftermath of cancer. To assess the subjective severity and 
perceived aftermath of cancer, each participant responded to two questions. Participants were 
asked to indicate the extent to which they considered both their cancer and the aftermath of 
their cancer to be serious on an 11-point Likert scale (0=not serious at all, 10=very serious).  
Statistical analyses 
To explore the prevalence of PTG among Hungarian cancer patients, we used Schoevers & 
Teo‟s method. PTGI items were dichotomised as follows: 0=item endorsed between „not at 
all‟ and a „small degree‟ (answer rating 0, 1, or 2) and 1=item endorsed between a „moderate 
degree‟ and a „very great degree‟ (answer rating 3, 4, or 5). The total score was then 
calculated (between 0 and 21) and used for descriptive aims. For the correlational and 
regression analyses, the continuous PTGI total score was used.  
Associations between the sociodemographic and cancer-related variables and PTG were 
determined using Student’s t-test, the Mann-Whitney U test, Welch's t-test, analyses of 
variance (ANOVA), the Kruskal-Wallis test, or the Pearson/Spearman correlation. In 
addition, Pearson or Spearman correlations were calculated to examine the associations 
between HRQoL and PTG and the relationships between adult attachment and PTG, 
respectively. Brennan et al. asserted that individuals could be placed into four attachment 
categories based on their scores on the Attachment Anxiety and Attachment Avoidance 
subscales. In the present study, participants were placed into those four attachment-style 
categories using cluster analysis. Attachment categories were analysed by three different 
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clustering methods (K-means clustering, Ward‟s method, and the unweighted pair-group 
average with Euclidean distance). As all methods resulted in almost the same cluster 
structure, the classifications were compared to each other. The K-means classification was 
chosen for further analyses as this one differed less from the others. The four attachment-style 
categories (as the four clusters) explained 62.1% of the variance in ECRS total score, 80.73% 
of the variance in Attachment Avoidance subscale, and 77.7% of the variance in Attachment 
Anxiety subscale. The differences in PTG (total and subscale scores) between participants in 
the four attachment-style categories were analysed using ANOVA, Kruskal-Wallis test, 
Student’s t-test, and the Mann-Whitney U test. Finally, hierarchical multiple regression 
analyses were performed to investigate the unique contribution of each variable to the PTGI 
total score and its subscales. In the first step of each regression model, sociodemographic and 
cancer-related variables (including subjective severity and perceived aftermath of cancer) that 
were significantly related to the dependent variable in the initial bivariate analyses were 
entered into the model. In the subsequent steps, other variables (HRQoL and adult 
attachment) that were significantly related to the dependent variable in the initial bivariate 
analyses were entered individually into the regression model. The significance level for all 
analyses was defined as 0.05.  
 
Results 
Descriptive statistics 
The mean PTGI score was 63.53 (SD=22.07, range 0-103). The mean item rating was 3.02 
(range 0-5), which indicated a “moderate degree of positive change” (on the 6-point Likert 
scale) as a result of the cancer experience. As in the study by Schroevers and Teo, the PTGI 
items endorsed by patients to a “moderate degree” or greater were computed. On average, the 
participants endorsed 14 of the 21 PTGI items (M=14.3, SD=5.16; range 0-21) to a “moderate 
degree” or greater (≥3 on the 0-5 scale). According to this computation, the top four most 
frequently endorsed items of PTGI were “Having more compassion for others” (85.5%, 
Relating to Others subscale), “Better appreciation for each day” (84.8%, Appreciation of Life 
subscale), “Knowing I can count on people in times of trouble” (84.2%, Relating to Others 
subscale), and “Knowing better that I can handle difficulties” (83.5%, Personal Strength 
subscale).  
The mean FACT-G score was 81.54 (SD=16.73, range 39-108), and the mean ECRS score 
was 93.65 (SD=37.92, range 36-196). The average perceived severity and the average 
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perceived aftermath of cancer were both moderately serious (M=4.69, SD=2.54; and M=4.78, 
SD=2.77, respectively). As recommended by Brennan et al., participants were placed into four 
attachment-style categories. In the current sample, 40.7% were categorised as secure, 15.1% 
were categorised as fearful, 25.6% were categorised as preoccupied, and 18.4% were 
categorised as dismissive. 
Relationships between sociodemographic and cancer-related variables and 
posttraumatic growth 
First, we examined the relationships between the PTG (total score and its subscale scores) and 
various sociodemographic and cancer-related variables. Women with breast cancer reported a 
significantly higher score than men with prostate cancer for the PTGI total and its subscales 
(except New Possibilities). There were significant negative correlations between age and 
PTGI total and its subscales (except Personal Strength). The Mann-Whitney and t-tests 
revealed that married patients and those who lived with a partner scored higher on the 
Appreciation of Life (10.8 vs. 8.8, p<0.01), New Possibilities (12.96 vs. 10.3, p<0.05), and 
Spiritual Change (3.86 vs. 2.63, p<0.05) subscales compared to patients who were not 
married and did not live with a partner. Education levels were not significantly associated 
with PTGI total and subscale scores.  
Significant group differences were found among patients with different stages of cancer for 
the PTGI total score and the Appreciation of Life and Relating to Others subscales, such that 
individuals with stage I, II or III cancer reported significantly higher scores than those with 
stage IV cancer. There were no statistically significant associations between the PTGI total 
score or its subscales and the use of chemotherapy or the history of 
mastectomy/prostatectomy with one exception. Participants who were treated with 
chemotherapy and participants who underwent a mastectomy/prostatectomy reported 
significantly higher scores on the Appreciation of Life subscale compared to those who were 
not treated by these treatments (10.79 vs. 9.52, p<0.05; 11.48 vs. 9.84, p<0.05, respectively). 
Subjective severity of cancer and its perceived aftermath were significantly positively 
correlated with PTGI total score and most of its subscales. Nevertheless, no significant 
correlations were found between subjective severity and stage (p=0.23) or between perceived 
aftermath of cancer and stage (p=0.52). Analyses of time since diagnosis and the effects of 
hormonal therapy on PTGI scores did not yield any significant differences.  
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Quality of life, adult attachment, and posttraumatic growth 
There was no significant association between the total score obtained on the PTGI and the 
FACT-G total score. Only the SFWB subscale score was significantly positively correlated 
with the PTGI total and its subscale scores. Moreover, the Personal Strength subscale 
demonstrated significant positive correlations with the HRQoL total score (FACT-G) and the 
well-being subscales (except PWB). We did not find a significant relationship between the 
PTGI total score and adult attachment. Only one significant correlation was observed between 
Personal Strength and Attachment Avoidance (r=-0.203). The differences in PTG (total and 
subscale scores) between participants in the four attachment-style categories were analysed. 
Significant group differences were found in Personal Strength score (chi
2
=13.13, p<0.01) and 
in Relating to Others score (F=6.11, p<0.05), such that participants with dismissive 
attachment reported significantly lower scores than those with secure, preoccupied, and 
fearful-avoidant attachment.  
Predictors of posttraumatic growth 
Hierarchical multiple regression analyses were conducted to examine the relative contribution 
of each variable that was previously related to PTGI total or PTGI subscale scores. The 
analyses resulted in a significant model (F=10.310, p<0.001) that explained 29.9% of the 
variance in PTGI total score. Age (β=-0.177, p=0.020), subjective severity (β=0.173, 
p=0.039), and SFWB (β=0.377, p<0.001) were significant predictors of PTGI total score. For 
the prediction of Appreciation of Life, the final model (F=7.924, p<0.001) explained 33.4% 
of the variance. Subjective severity (β=0.228, p=0.006), mastectomy/prostatectomy 
(β=0.224, p=0.004), and SFWB (β=0.276, p<0.001) were significant predictors of 
Appreciation of Life. For the prediction of New Possibilities, the final model (F=9.816, 
p<0.001) explained 25.2% of the variance. Younger age (β=-0.259, p=0.001), subjective 
severity (β=0.211, p=0.014), and SFWB (β=0.263, p<0.001) were significant predictors of 
New Possibilities. In the case of Personal Strength, the final model was significant (F=7.203, 
p<0.001) and accounted for 25.9% of the variance. Gender (β=-0.209, p=0.005), FWB 
(β=0.214, p=0.012), and Dismissive attachment (β=-0.266, p=0.007) were significant 
predictors of Personal Strength. For the prediction of Spiritual Change, the final model 
(F=6.387, p<0.001) explained 17.9% of the variance. Gender (β=-0.181, p=0.028) and SFWB 
(β=0.231, p=0.003) were significant predictors of Spiritual Change.  Finally, for the 
prediction of Relating to Others, the final model was significant (F=6.700, p<0.001) and 
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accounted for 29.8% of the variance. SFWB (β=0.393, p<0.001) and Dismissive attachment 
(β=-0.207, p=0.033) were significant predictors of Relating to Others.    
Discussion 
 
The aim of this cross-sectional study was to examine the relationships between PTG, 
sociodemographic and cancer-related variables, HRQoL, and adult attachment in a sample of 
152 cancer patients. Analyses revealed that the majority of patients (85%) experienced 
positive psychological changes as a result of their struggles with cancer. The top four most 
frequently endorsed items on the PTGI fell within three subscales: Appreciation of Life, 
Relating to Others, and Personal Strength. Hierarchical multiple regression analyses were 
performed on PTGI total and subscale scores to reveal their possible predictors. We found 
that younger age was a significant predictor of higher PTGI total score and New Possibilities 
score. A negative association between age and PTG is commonly reported in the literature. A 
possible explanation is that a cancer diagnosis may be more disruptive and distressing for 
younger people, and a greater threat may prompt more growth. Another explanation is that 
younger patients
 
may regard cancer to be more challenging, which activates more resources 
for positive re-evaluation and redefining of life goals and priorities, compared to older ones. 
In addition, higher Spiritual Change and Personal Strength subscale scores were predicted by 
female gender.   
Among the cancer-related variables, undergoing a mastectomy or prostatectomy was a 
significant predictor of higher scores on the Appreciation of Life subscale. Moreover, greater 
subjective severity of cancer was a predictor of increased PTGI total score and scores on the 
Appreciation of Life, Spiritual Change, Relating to Others, and New Possibilities subscales. 
This is in line with previous studies that found a positive association between the subjective 
appraisal of cancer and PTG (but found no association between the stage of cancer and PTG); 
people who perceive their cancer as a traumatic/highly stressful event were more likely to 
report PTG. According to the theory of PTG, the subjective seriousness of the event is a 
determining factor for the experience of personal growth; that is, a certain level of threat is 
necessary to challenge one‟s existing schemata about the world.  
Regarding HRQoL, SFWB was a significant predictor of PTGI total score and scores on the 
New Possibilities, Appreciation of Life, Spiritual Change, and Relating to Others subscales. 
Thus far, no study has explored the relationship between SFWB and PTG. However, in the 
present study, SFWB may refer to the perceived social support of the sample. Social support 
is usually reported to be positively associated with positive psychological changes in psycho-
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oncological studies. The support of family members and friends, the expression of positive 
emotions toward the patient, and the regular discussion of problems relating to cancer can 
foster greater awareness of the positive changes resulting from the illness. Moreover, a 
positive relationship was found between FWB and the Personal Strength subscale, that is, 
patients who endorsed higher FWB perceived themselves as having greater Personal Strength.  
In connection to the relationship between adult attachment and PTG, we found that dismissive 
attachment style predicted fewer scores on the Personal Strength and Relating to Others 
subscales. Dismissing persons have high levels of attachment avoidance and low levels of 
attachment anxiety. They prefer not to get close to their partners because of their negative 
expectations. This attachment style may hinder the experience of growth in the domain of 
close relationships. Moreover, dismissing individuals maintain a sense of self-worth by 
denying the importance of close relationships. Due to their positive self model, they may have 
less room for growth in the field of Personal Strength.  
 
 
Longitudinal study 
 
Research hypotheses 
 
The other large part of our study was a longitudinal study, which had the aim to investigate 
the patterns of change in HRQoL, fatigue, and PTG with a sample of breast and prostate 
cancer patients during a three-month period. All the patients completed measures at three time 
points as follows: one or two weeks before the start of RT, in the fifth/sixth week of 
treatment, and four to six weeks post-treatment. The hypotheses of the study were as follows: 
Hypothesis 1: Cancer patients‟ quality of life would significantly decrease during RT 
but would significantly improve after treatment ended. 
Hypothesis 2: PTG would significantly increase during the three-month period.   
Hypothesis 3: We assumed that the fatigue reported by patients would worsen during 
the course of RT but would decrease after treatment ended. 
Because of the highly inconsistent results of previous studies, we had no hypothesis regarding 
the relationship between PTG and HRQoL.   
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Methods 
Procedures 
The study sample was recruited from the Department of Radiotherapy at the University of 
Debrecen. The inclusion criteria for the study were the following: (1) no previous cancer 
history; (2) primary breast or prostate cancer without distant metastases; (3) imminent 
initiation of external beam radiotherapy; and (4) more than 18 years of age. Our sample 
consisted of patients with either breast or prostate cancer, given that these diseases have 
similar RT treatment regimens and cause similar impairments in the quality of life. All 
questionnaires were administered three times. For the first wave, eligible patients were 
identified and then provided with information about the study by a psychologist after a 
session of radiation simulation (one or two weeks before the start of RT). Participants 
completed a written informed consent form and a questionnaire packet (T1). For the second 
and third waves, questionnaires were mailed to the patients in the fifth/sixth week of RT 
treatment (T2) and four to six weeks after the end of RT (T3). The study was approved by the 
Medical Ethical Committee from the Medical and Health Science Center at the University of 
Debrecen.  
 Participants 
A total of 152 individuals were approached to participate in this study before RT (T1) (74.3% 
female patients; mean age: 59.1 years, SD=10.7, range 34-80). Of the 152 patients, 91 
(59.8%) completed questionnaires at T2 and T3 (84.6% female patients; mean age: 58.7 
years, SD=10.6, range 34-78). Attrition bias was examined by testing whether any systematic 
differences existed between patients missing at the follow-ups and patients who participated 
in all of the assessments. No significant differences were found between the two samples in 
socio-demographic and medical variables. Of the 91 patients, 65.9% were married or lived 
with a partner (N=60), and a significant number reported having a secondary education 
(N=60, 65.9%). The mean length of time since diagnosis was 3.7 months (SD=2.5, range 0.2-
7.6). The disease stages at diagnosis were Stage I (46.1%), Stage II (36.3%), Stage III 
(14.3%), or Stage IV (3.3%). All patients had undergone some form of surgery, but only 
15.4% (N=14) had undergone a mastectomy or prostatectomy. Many patients were treated by 
chemotherapy (N=43, 47.3%) and a majority were treated by hormonal therapy (N=66, 
72.5%).  
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Measures 
All questionnaires were administered three times.  
 Time 1 (T1): the following questionnaires were completed after a session of radiation 
simulation (one or two weeks before the start of RT): 
- Posttraumatic Growth Inventory (PTGI) 
- Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G 
version 4) 
- Feelings of fatigue have been explored with the following two individual items 
from the Physical Well-being subscale of FACT-G: “I have a lack of energy” 
and “I am forced to spend time in bed”. 
-  Socio-demographic and medical variables: The following socio-demographic 
variables were assessed: age, gender, marital status, and education. The 
following medical variables were derived from patients‟ medical charts: the 
stage of the cancer, the type of treatment received (e.g., type of surgery, 
hormonal therapy, chemotherapy), and the length of time elapsed since 
diagnosis.  
 Time 2 (T2): the following questionnaires were completed in the fifth/sixth week of RT 
treatment: 
- Posttraumatic Growth Inventory (PTGI) 
- Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G 
version 4) 
- Feelings of fatigue have been explored with the following two individual items 
from the Physical Well-being subscale of FACT-G: “I have a lack of energy” 
and “I am forced to spend time in bed”. 
 Time 3 (T3): the following questionnaires were completed four to six weeks after the end 
of RT:  
- Posttraumatic Growth Inventory (PTGI) 
- Functional Assessment of Cancer Therapy-General Questionnaire (FACT-G 
version 4) 
- Feelings of fatigue have been explored with the following two individual items 
from the Physical Well-being subscale of FACT-G: “I have a lack of energy” 
and “I am forced to spend time in bed”. 
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Statistical analyses 
Descriptive statistics were measured for normalcy, and means, standard deviations, ranges, 
and counts for the variables were calculated. Chi-square tests, t-tests or Mann-Whitney U tests 
were used to determine whether those patients who did not complete all of the assessments 
differed from those who completed all of the assessments with regard to socio-demographic 
and medical variables. The relationships between the socio-demographic, medical variables 
and the PTG and FACT-G were determined using t-tests, the Mann-Whitney U test, Welch's t-
tests, analyses of variance (ANOVA), or the Kruskal-Wallis test. Pearson or Spearman 
correlations were calculated to reveal associations between the FACT-G and PTG. Pairwise 
comparisons of the two individual fatigue-related items‟ scores at T1, T2, and T3 were 
completed with Wilcoxon paired signed-rank tests. Finally, repeated measures analyses of 
variance were conducted to examine whether there were significant changes in FACT-G 
scores and PTGI scores throughout the duration of the study. Bonferroni’s method was used 
for multiple comparisons of FACT-G scores and PTGI scores at T1, T2, and T3. The 
significance level for all analyses was defined as 0.05.  
Results 
Relationships of socio-demographic and medical variables to HRQoL and PTG 
Preliminary analyses were conducted to examine whether socio-demographic or medical 
variables were related to HRQoL or PTG at the three measurement times. We found that 
neither PTGI total scores nor FACT-G total scores were significantly associated with any of 
the socio-demographic (i.e., age, gender, education, and marital status) or medical (i.e., stage, 
mastectomy/prostatectomy, hormonal therapy, chemotherapy, and time since diagnosis) 
variables at T1, T2, and T3.    
Changes in HRQoL 
The FACT-G total scores significantly declined between T1 and T2, and then significantly 
increased between T2 and T3. No significant difference was found between the FACT-G total 
scores at T1 and T3. The same pattern was found for the PWB subscale: scores significantly 
decreased during RT (T2), and then returned to baseline levels four to six weeks after RT 
ended (T3). During RT (T2), the SFWB score was significantly lower than the baseline 
SFWB score (T1), and it remained low at the time of the third measurement (T3). EWB did 
not significantly change during the time period of the study. The FWB scores significantly 
decreased between T1 and T2, and then showed nonsignificant improvement by T3. 
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Comparisons of the baseline HRQoL scores (T1) and the HRQoL scores at T3 revealed that 
none of the subscale scores at four to six weeks after RT ended (T3) were significantly 
different from the baseline scores (T1), except for the SFWB score. This result means that all 
of the well-being scores returned to the baseline scores four to six weeks after RT. 
Changes in PTG 
The PTGI total score and the subscales for New Possibilities, Personal Strength, and Relating 
to Others remained relatively stable throughout the measurements. The Appreciation of Life 
scores increased but not significantly at T2 compared with T1, and then significantly declined 
between T2 and T3. The Spiritual Change scores significantly increased during RT (T2), and 
this improvement was maintained four to six weeks after RT ended (T3).   
Relationships between HRQoL and PTG 
There were no statistically significant correlations between the PTGI total scores and the 
FACT-G total scores (at T1, T2, and T3). However, significant negative correlations were 
found between PWB scores and PTGI total scores. The strongest correlation was between the 
PWB score at T1 and the PTGI total score at T3 (r=-0.26, p<0.01). Moreover, significant 
positive correlations were revealed between SFWB subscales and PTGI total scores at all 
points of measurement. The strongest correlation was between the SFWB subscale and the 
PTGI total score at T1 (r=0.34; p<0.01). 
Changes in fatigue 
Changes in feelings of fatigue were calculated by separating the two fatigue-related items 
from the PWB subscale of the FACT-G. The results derived from these two items show the 
same pattern of change, in that patients felt significantly more fatigue during RT (T2) 
compared with the baseline measurement (T1). However, fatigue significantly decreased by 
four to six weeks after RT ended (T3). Thus, the feeling of fatigue increased during RT, but it 
returned to the baseline level some weeks after the treatment ended.    
Discussion 
 
This study is the only one available in the psycho-oncological literature that examined the 
relationship between HRQoL and PTG among breast and prostate cancer patients undergoing 
RT. We used a longitudinal design to measure HRQoL and PTG before, during (in the 
fifth/sixth week of the treatment), and after RT (four to six weeks after the end of treatment).  
20 
 
According to our results, neither PTGI total scores nor FACT-G total scores were 
significantly associated with any of the socio-demographic or medical variables during the 
study period. We found a significant deterioration in overall quality of life (FACT-G total) 
and PWB at the fifth/sixth week of RT. However, by four to six weeks after RT had ended, 
both of these variables showed improvement and had returned to their baseline levels. The 
FWB score decreased during RT, and then started to increase by four to six weeks post-
treatment, but only to a small degree. 
EWB was the only domain of HRQoL that remained unchanged, which is in line with results 
from a previous study reporting that RT recipients and healthy comparison subjects do not 
differ with regard to levels of anxiety and depressive symptoms. This result may suggest that 
a relative emotional equilibrium was typical for these patients during and shortly after RT in 
contrast with the upheaval caused by the diagnosis.  
We observed a significant decline in the SFWB score during RT and that this was the only 
domain of HRQoL that did not return to the baseline level after RT ended. This result is in 
line with the study of Dow and Lafferty that found that social functioning significantly 
decreased during RT and remained lower by six months post-treatment. Although the specific 
cause of this decrease in SFWB could not be determined in this study, it is possible that 
during and shortly after RT patients temporarily withdraw from their social support system 
because of the experienced side effects caused by the RT.  
Overall, we found that all of the well-being scores (except for EWB) significantly decreased 
during RT. However, by four to six weeks after RT had ended, all of them improved and 
returned to their baseline scores (except for SFWB, which did not return). The changes in 
HRQoL within this sample were similar to those reported in previous studies. For example, 
Stone et al. observed significant decreases in role, cognitive, and social functioning by the last 
week of RT. They also found that emotional functioning did not change during this period. A 
study conducted by Dow and Lafferty revealed that, by the midpoint of RT, significant 
deterioration had occurred in social, family, and psychological/spiritual functioning. By six 
months post-treatment, all of these factors improved with the exception of social functioning, 
which remained low.  
Our hypothesis that fatigue reported by patients may worsen during the course of RT was 
supported by the results of this study. A clinically significant increase in fatigue was found 
during the RT, but it returned to the baseline level four to six weeks after the end of treatment. 
This finding is consistent with some previous studies that found the same pattern of change in 
fatigue among cancer patients receiving RT.  
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The overall PTG and most of its subscales did not change significantly during the time period 
of this study. Only two subscales were exceptions: Appreciation of Life and Spiritual Change. 
Appreciation of Life showed an increasing trend during RT, and then it significantly declined 
four to six weeks after the treatment ended. It is possible that receiving RT treatment 
constantly reminds a person of his/her illness and the possible danger of death, which can 
enhance feelings of appreciation and respect for life. However, after the treatment this 
“memento” may disappear, making the Appreciation of Life decrease. Moreover, Spiritual 
Change significantly increased during RT, and this improvement was maintained four to six 
weeks post-treatment. RT treatment may serve as a reminder of the threat of death, which can 
precipitate sensitivity to the transcendent. This experience may continue after the RT, as the 
signs of recovery (e.g., better HRQoL) confirm the relationship with the transcendent (e.g., 
God).   
As expected, no significant associations were found between the PTGI total scores and the 
FACT-G total scores. Nevertheless, we found significant negative correlations between PWB 
and PTGI total scores: people with lower PWB reported greater PTG. Physical symptoms 
may remind patients of the threat caused by their illness and, as other studies have shown, 
greater feelings of threat may prompt more positive changes (PTG). In addition, positive 
correlations were reported between SFWB and PTGI total scores, indicating that patients with 
greater perceived social support experienced more positive changes. Several studies have 
found that social support is a determining factor in finding benefits in a life-threatening 
illness. The possibility for patients to disclose negative cancer–related emotions (e.g., fear) 
and the empathy and compassion coming from family members and friends can contribute to 
greater awareness of positive changes that result from an illness.  
Although we found significant impairment in HRQoL during RT, it is important to note that 
RT has a highly relevant role in the curative and palliative treatment of cancer. For example, 
RT can significantly decrease the incidence of intra-breast tumor reappearance in the case of 
breast cancer. Moreover, this decline in quality of life is only transient, as Deshiels et al. 
demonstrated that psychological “recovery” occurs two weeks after the end of RT. It may be 
important for future research to compare changes in HRQoL during chemotherapy to changes 
in HRQoL during RT, since as Conner-Spady et al. found, the pattern of change in HRQoL 
during chemotherapy can be similar to our results.  
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Summary 
 
The oncological treatment of cancer patients puts less stress on the psychological processes 
happening in patients during the fight against the illness.  Facing the diagnosis of cancer 
usually means a psychological trauma for patients, initiating a psychological crisis. This crisis 
may have not only a negative impact on people but may foster positive changes. The 
phenomenon of posttraumatic growth (PTG) is a relatively unexplored research area in 
Hungarian oncopsychology. Making up this shortage, a cross-sectional study has been 
accomplished with the participation of 152 cancer patients. We wondered whether Hungarian 
cancer patients experience positive changes coming from the struggle with this serious illness, 
what the prevalence of PTG is, and what kind of associations there are between PTG and 
person-related and cancer-related variables. According to our results, the majority of patients 
(85%) experienced positive changes, at least to a moderate degree, as a result of their cancer. 
Among the cancer-related variables, undergoing a mastectomy or prostatectomy and greater 
subjective severity of cancer were significant predictors of higher PTG scores. Regarding 
person-related variables, we found that younger age, female gender (in some ways), and 
persons with higher Social/Family well-being experienced higher PTG. Moreover, persons 
with a dismissive attachment style reported lower scores on two subscales of PTG. These 
results draw attention to the importance of PTG, which can assist patients in adjusting to 
cancer symptoms and the side effects of its treatment. 
The number of longitudinal studies examining the health-related quality of life of cancer 
patients during and after radiotherapy (RT) is, surprisingly, quite low. For the sake of raising 
this number, a longitudinal study analysing the changes in quality of life, PTG and fatigue has 
been realized with the participation of 91 cancer patients. The results from this analysis 
suggest that significant declines in HRQoL and fatigue are evident in the fifth/sixth week of 
RT treatment. However, by four to six weeks after RT had ended, these variables improved 
and returned to their baseline scores (except for Social/Family well-being, which did not 
return). The PTG total score and almost all of its subscale scores did not change significantly 
during the period of the study. However, the subscale of Spiritual Change for PTG 
significantly increased during RT, and sustained this improvement at four to six weeks post-
treatment. The results of this longitudinal study may emphasize the relevancy of proper 
information for patients about the probable side effects of RT and their effective management 
before the start of treatment. 
23 
 
List of publications
24 
 
 
 
25 
 
Conference presentations related to the thesis 
Tanyi Zs: A trauma, mint esély a fejlődésre. Oral presentation at the 10th 
Magatartástudományi Napok, Pécs, 2010. május 25-26. 
Zs. Tanyi: Posttraumatic growth and other psychological factors in cancer patients. Poster 
presentation at the 4
th
 Conference of Népegészségügyi Képző- és Kutatóhelyek, 
Szombathely, 2010. szeptember 2-4. 
Tanyi Zs.: A trauma transzformatív ereje: a poszttraumás növekedés. Oral presentation at 
the Pszichológia Napja (MPT Kelet-Magyarországi Tagozata). Lélek-életmód-egészség, 
Debrecen, 2011. február 25. 
Tanyi Zs.: A halállal való szembesülés pszichológiája és etikája Fritz Zorn Mars című 
regényében. Oral presentation at the Conference of Bioetikai témák a művészetben.  
Debrecen, 2011. április 29. 
Zs. Tanyi: Diagnosis of cancer: a source of posttraumatic growth. Poster presentation at 
the 12
th
 European Congress on Traumatic Stress, Vienna, June 2-5, 2011. 
Zs. Tanyi: Diagnosis of Cancer: A Source of Posttraumatic Growth. Poster presentation at 
the 5
th
 Conference of Népegészségügyi Képző- és Kutatóhelyek. Szeged, 2011. augusztus 
31-szeptember 2.  
Tanyi Zs., Bugán A., Szluha K.: A daganatos betegség okozta személyiségbeli pozitív 
változások. Oral presentation at the 29
th
 Conference of Magyar Onkológusok Társasága, 
Budapest, 2011. november 10-12. 
Tanyi Zs.: A daganatos betegség okozta lelki fejlődés: a poszttraumás növekedés. Oral 
presentation at the 3
rd 
Conference of Sugárterápia a klinikai gyakorlatban, Debrecen, 
2012. február 3-7. 
Tanyi Zs.: A daganatos betegség okozta trauma. Avagy amikor a rózsaszín szemüveg 
eltörik. Oral presentation at the 12
th
 Conference of Magatartástudományi Napok, Szeged, 
2012. június 14-15.   
Zs. Tanyi, A. Bugán, K. Szluha: Positive consequences of cancer as a psychological 
trauma. Poster presentation at the 13
th
 International Congress of Behavioral Medicine, 
Budapest, 29 August-1 September, 2012. 
Tanyi Zs.: Onkológiai betegek poszttraumás személyiségfejlődésének és más lélektani 
jellemzőinek kapcsolata. Oral presentation at the 6th Conference of Népegészségügyi 
Képző- és Kutatóhelyek, Budapest, 2012. szeptember 5-7. 
26 
 
Tanyi Zs.: A rák okozta lélektani krízis és a poszttraumás növekedés. Oral presentation at 
Conference of A krízis hermeneutikája. Válság, válságtudat, identitás, Debrecen, 2012. 
szeptember 28-29.  
Tanyi Zs., Bugán A., Szluha K.: A poszttraumás növekedés vizsgálata magyar daganatos 
betegek körében. Oral presentation at the 13
th
 Conference of Magatartástudományi Napok, 
Debrecen, 2013. június 20-21. 
 
Other conference presentations 
Tanyi Zs.: „Fiam! Te beteg vagy!” Óvodás gyermekek betegség-reprezentációja. Oral 
presentation at the 29
th
 Conference of Országos Tudományos Diákkör, Pécs, 2009. április 
6-8. 
Tanyi Zs.: „Fiam! Te beteg vagy!” Óvodás gyermekek betegség-reprezentációja. Oral 
presentation at the 23
rd 
Conference of Magyar Családterápiás Egyesület, 2009. április 17. 
Tanyi Zs.: Milyen a betegség a gyermek szemszögéből? Oral presentation at the 13th 
Conference of Pszinapszis- Budapesti Pszichológiai Napok, 2009. április 18-19. 
Tanyi Zs.: Milyen a betegség a gyermek szemszögéből? Poster presentation at the 13th 
Conference of Pszinapszis - Budapesti Pszichológiai Napok, 2009. április 18-19. 
Tanyi Zs.: A bölcsesség pszichológiai megközelítése és alkalmazása a pszichoterápiás 
munka során. Oral presentation at the 11
th
 Conference of Magatartástudományi Napok, 
Gödöllő, 2011. június 28-29.  
